191 filings
Page 2 of 10
8-K
xrnvec1
31 Mar 23
Submission of Matters to a Vote of Security Holders
11:04am
8-K
l3jj0
14 Mar 23
Other Events
12:31pm
8-K
m19r3
9 Feb 23
Veru Reports Fiscal 2023 First Quarter Financial Results
7:01am
8-K
p9v8pflbi pf
5 Dec 22
Veru Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
7:01am
8-K
40g3exd25y hvs4
11 Aug 22
Results of Operations and Financial Condition
7:01am
8-K
evjcbp c2
12 May 22
Veru Reports Second Quarter Fiscal 2022 Results and Progress of Sabizabulin for COVID-19 Toward a Request for Emergency Use Authorization
7:00am
8-K
pqjjuo 42fgukpa0
31 Mar 22
Departure of Directors or Certain Officers
4:06pm
8-K
qcfz9ykjtr
9 Feb 22
Results of Operations and Financial Condition
7:00am
8-K
kyv5 uu1mb
2 Dec 21
Veru Reports Record Fiscal 2021 Full-Year Financial Results
7:01am
8-K
35jl0 hfmnlkezwib44
12 Aug 21
Veru Sets Another Quarterly Record in Both Net Revenues
10:04am
8-K
68w7fkmrmia01m 4ul0m
14 May 21
Departure of Directors or Certain Officers
4:34pm
8-K
mt4ig 5xnwg8
12 May 21
Veru Reports Strong Second-Quarter Financial Results Based on Record High FC2 Prescription Revenues
7:00am
8-K
eugwwzpg
26 Mar 21
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
fhxhyc3y
18 Feb 21
Veru Announces Proposed Public Offering of Common Stock
4:39pm
8-K
rh8x0
10 Feb 21
Veru Sets Another Quarterly Record in Both Net Revenues
7:00am
8-K
8r7avqi0rrnpsj4o2v
9 Dec 20
Veru Reports Record Fiscal 2020 Fourth Quarter and Record Full-Year Financial Results
7:00am
8-K
yr1zimznma6a6bk9vs
13 Aug 20
Veru Reports Higher Net Revenues for Fiscal 2020 Third Quarter
7:00am
8-K
uxb bj8t3j7s3ab
26 Jun 20
Entry into a Material Definitive Agreement
4:06pm
8-K
l7fucdpun
13 May 20
Veru Reports Strong Fiscal 2020 Second Quarter Results as Operating loss significantly narrowed to $0.3 million from $2.1 million; and
7:00am
8-K
mlt7oyji 2vej
26 Mar 20
Departure of Directors or Certain Officers
12:06pm